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Abstract
Recent advances in medical imaging techniques have led
to significant improvements in the management of prostate
cancer (PCa). In particular, multi-parametric MRI (mp-
MRI) continues to gain clinical acceptance as the preferred
imaging technique for non-invasive detection and grading
of PCa. However, the machine learning-based diagnosis
systems for PCa are often constrained by the limited ac-
cess to accurate lesion ground truth annotations for train-
ing. The performance of the machine learning system is
highly dependable on both quality and quantity of lesion an-
notations associated with histopathologic findings, result-
ing in limited scalability and clinical validation. Here, we
propose the baseline MRI model to alternatively learn the
appearance of mp-MRI using radiology-confirmed negative
MRI cases via weakly supervised learning. Since PCa le-
sions are case-specific and highly heterogeneous, it is as-
sumed to be challenging to synthesize PCa lesions using
the baseline MRI model, while it would be relatively easier
to synthesize the normal appearance in mp-MRI. We then
utilize the baseline MRI model to infer the pixel-wise suspi-
ciousness of PCa by comparing the original and synthesized
MRI with two distance functions. We trained and validated
the baseline MRI model using 1,145 negative prostate mp-
MRI scans. For evaluation, we used separated 232 mp-MRI
scans, consisting of both positive and negative MRI cases.
The 116 positive MRI scans were annotated by radiologists,
confirmed with post-surgical whole-gland specimens. The
suspiciousness map was evaluated by receiver operating
characteristic (ROC) analysis for PCa lesions versus non-
PCa regions classification and free-response receiver oper-
ating characteristic (FROC) analysis for PCa localization.
Our proposed method achieved 0.84 area under the ROC
curve and 77.0% sensitivity at one false positive per patient
in FROC analysis.
1. Introduction
Prostate cancer (PCa) is one of the most common cancer-
related diseases among men in the United States [11]. Re-
cent advances in medical imaging have led to significant im-
provements in the management of PCa. In particular, multi-
parametric magnetic resonance imaging (mp-MRI) contin-
ues to gain clinical acceptance as the preferred imaging
technique for non-invasive detection and grading of PCa.
However, the current standardized image acquisition and re-
porting structure of prostate MRI, such as Prostate Imaging
- Reporting and Data System version 2 (PI-RADSv2), has
limited ability to accurately distinguish between indolent
and clinically significant PCa due to its qualitative or semi-
quantitative assessment of the imaging [14]. As a result,
there often exists over-detection of indolent PCa and under-
detection of csPCa, which lead to detrimental overtreatment
and undertreatment. Consequently, there is an urgent clini-
cal need to achieve accurate detection and classification of
csPCa.
Recent studies have explored quantitative interpretations
of mp-MRI by training machine learning models [6, 12,
13, 15, 2]. Most of the machine models were trained un-
der strong supervision using the lesion annotations as the
ground truth, and thus the performance of the models is de-
pendent on both quantity and quality of training data asso-
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ciated with ground truth annotations. However, the radio-
logic findings from mp-MRI are not easy to be fully inte-
grated with histologic findings due to misregistration or in-
sufficient histologic information, resulting in a limited num-
ber or quality of ground truth annotations available. Litjens
et al. used MR-guided biopsy dataset to identify biopsy-
confirmed lesions in MRI [6], and Fehr et al. annotated PCa
region of interest (ROI) using post-surgical whole-gland
specimens as a reference [2]. Nevertheless, both studies
used relatively small numbers of cases (348 and 147 cases,
respectively) due to the limited availability of ground truth
annotations.
In contrast, the number of mp-MRI scans has been in-
creased in recent years as mp-MRI gains clinical acceptance
for a non-invasive diagnostic tool for detecting and grading
PCa. Many of mp-MRI scans are sometimes ruled out to be
MRI negative, showing no visible MRI lesions. The nega-
tive MRI case is shown to be reliable without the need for
histologic confirmations [4]. Thus, the collection of nega-
tive MRI scans is more plausible to access in a large quan-
tity than the collection of positive MRI scans with accu-
rate lesion annotations. While the negative MRI scans are
vastly available, the existing machine learning models for
detection of PCa cannot solely learn from the negative MRI
scans since they need to be trained under strong supervision
between normal and PCa lesions.
In this work, we first propose the baseline MRI model
that learns the general appearance of prostate MRI from
the negative MRI scans. The baseline MRI model is im-
plemented as a convolutional neural network (CNN) to syn-
thesize a partially-obstructed region of a prostate MR im-
age using the rest of the unobstructed image as the input via
weakly-supervised learning. Since PCa lesions are case-
specific and highly heterogeneous, it would be difficult to
synthesize PCa lesions when the baseline MRI model is
trained with only negative MRI scans while it is relatively
easy to synthesize the normal appearance of prostate MRI.
Based on this assumption, we use the trained baseline MRI
model to infer the cancer suspiciousness map. Given a test-
ing image set that contains both negative and positive MRI,
the baseline MRI model synthesizes for different regions
from the collection of regions of interest (ROIs), and the
cancer suspiciousness map is summarized by comparing the
original image regions and the synthesized image regions.
We summarize our contributions as follows. We pro-
posed the cancer inference that utilize the baseline MRI
model to predict pixel-wise levels of overall suspiciousness
via weakly supervised learning, without the need for PCa
annotations during training. We trained the baseline MRI
model using 1,145 negative mp-MRI scans, identified from
3,127 total collected mp-MRI scans from 2016 to 2018 at a
single institution. We evaluated the proposed cancer infer-
ence in a separate testing dataset, consisting of highly cu-
Figure 1. The baseline MRI model synthesizes for the partially ob-
structed region M (shown in orange) using an unobstructed image
as input.
rated 116 positive, confirmed with histologic whole-gland
specimens, and 116 negative mp-MRI scans.
2. Materials and methods
2.1. Negative prostate MRI
With IRB approval, we collected 3,127 3 Tesla (3T)
prostate mp-MRI scans from 2016 to 2018 at a single insti-
tution. MRI scans with following conditions were excluded:
1) patients scanned with non-3T MRI scanners, 2) patients
scanned with an endorectal coil, 3) patients scanned imme-
diately after prostate biopsy, and 4) patients underwent fo-
cal therapy and/or partial prostatectomy. Clinical radiology
reports associated with mp-MRI were used to identify neg-
ative MRI cases. We parsed the plain text in the report,
reviewed by genitourinary (GU) radiologists following the
standardized interpretation guideline of PI-RADSv2 [14],
into a structured format and identify MRI-negative cases
based on two criteria: 1) no suspicious target was seen in
Finding section, and 2) no more than mildly suspicious find-
ing in Impression section. We manually examined a random
subset to ensure the correctness of the identified negative
MRI cases. A total of 1,261 negative MRI scans were iden-
tified, and we divided them into training, validation, and
testing sets, containing 1,095, 50, and 116 cases, respec-
tively.
For each scan, we used the axial turbo spin-echo
(TSE) T2-weighted (T2w) (TR/TE, 3800-5040/101ms;
FOV, 14×14cm2; matrix, 256×205; slice thickness, 3 mm;
no gap) and maps of apparent diffusion coefficient (ADC)
using single-shot echo-planar imaging (SS-EPI) DWI
(TR/TE, 4800/80ms; FOV, 21×26cm2; matrix, 130×160;
slice thickness, 3.6 mm; b-values, 0/100/400/800 s/mm2).
ADC was registered into T2w, with 0.625×0.625mm2 in-
plane resolution and 3mm through-plane resolution. Both
T2w and ADC were cropped into a small field-of-view
(8×8cm2) to improve the model convergence. Four con-
secutive slices around mid and base gland were selected for
each scan, resulting in a total of 4,380 slices for training.
2.2. Baseline MRI model
The baseline MRI model, f , aims to recover a partially-
obstructed region, defined as a binary mask M , by
synthesizing similar appearance using the unobstructed
image,(1−M) I , as input for a given image, I . When
we stack T2w (IT2w) and ADC (IADC) as different imag-
ing channels (I = (IT2w, IADC)), the baseline MRI model
synthesizes, as shown in Figure 1, the specific region of the
stacked image by,
Mf
(
(1−M) I; θ)→MI, (1)
where θ is the trainable weights of the baseline MRI model.
We trained the baseline MRI model using only negative
MRI scans so that the baseline MRI model learns the vari-
ous normal prostate appearance of mp-MRI in training.
We used a U-Net CNN structure [10] for the baseline
MRI model since the encoder-decoder design of U-Net
helps to summarize the global anatomical information [1],
and the skip connections from U-Net simplify the training
for observed regions. The unmasked input was fed directly
into the last decoding layer without a need to learn through
the encoder-decoder. In addition, we used partial convolu-
tional layers instead of full convolutional layers to compen-
sate for the zeroed-out input region during encoding [7]. We
operated the baseline MRI model with 2D images due to the
non-isotropic resolution of mp-MRI.
A collection of ROI candidates, described by the com-
mon locations and shapes of PCa, was also constructed to
avoid learning from irrelevant areas in the image (e.g., mus-
cle, fat, bone, etc). A total of 1,055 2D ROIs was used from
a separate study cohort without any case overlapping [5].
For each 2D ROI, the in-plane location relative to the cen-
ter of the prostate was maintained, and the through-plane
position was ignored. Each ROI was converted into a bi-
nary mask for the baseline MRI model as an ROI candi-
date to specify a region M to synthesize. As all the ROI
candidates were considered in one plane, the collection of
ROI candidates, M, accounted for the common locations
and shapes of PCa. A prevalence map, P , constructed by
P =
∑
M∈MM is shown in Figure 2.
We trained the baseline MRI model using the combina-
tion of L1 loss, perceptual loss, and style loss [3]. The
VGG-19 network pre-trained for image classification is
used for the calculation of perceptual loss and style loss.
We only take the feature map from the first convolutional
layer for perceptual loss and style loss, since the network is
trained for natural images and the higher-level features are
not applicable to our context. The same weighting for loss
terms is used as in [7]. The baseline MRI model was trained
for 4,000 epochs using a mini-batch of eight 128 × 128
training images. The learning rate was set to 0.0002 in first
1,000 epochs and was reduced to 0.00005 in the remaining
3,000 epochs with the batch normalization for the encoder
Figure 2. The prevalence map, P , constructed by the collection of
ROI candidates, accounting for the common locations and shapes
of prostate cancer.
turned off as suggested in [7]. Common image augmenta-
tions, including shifting, left-right flipping, and gray value
variations [10], were applied. We also randomly combined
multiple ROI candidates together to accelerate training. The
training took two days using one NVIDIA Titan Xp GPU.
2.3. Cancer inference via baseline MRI model
The baseline MRI model was utilized to predict pixel-
wise levels of overall suspiciousness for a given testing im-
age. The baseline MRI model is assumed to synthesize bet-
ter when negative MRI is partially obstructed than when
positive MRI is partially obstructed since it was trained by
only negative MRI cases. The regions were considered to
be highly suspicious when the difference between the orig-
inal and synthesized regions is nontrivial. In each time, we
specify a region to synthesize from the collection of ROI
candidates, M ∈ M, and the synthesized image region
from the baseline MRI model is Mf ((1−M) It; θ) where
It = (ItT2w, I
t
ADC) is the testing image. By synthesizing
different image regions with different ROI candidates, we
can obtain the suspiciousness map by
Susp
(
It
)
=
1
P
∑
M∈M
dist
(
MIt,Mf
(
(1−M) It; θ)) ,
(2)
where dist
(
Iori, Isyn
)
is the distance function measuring
the pixel-wise difference between the original image region
and the synthesized image region, and P is the prevalence
map to normalize the suspiciousness map. Figure 3 illus-
trates the proposed cancer inference utilizing the baseline
MRI model via weakly supervised learning.
Two common distance functions were tested individu-
ally: T2w SSIM and ADC Increment, where SSIM is the
structural similarity, and Increment is the signal intensity
increment of the synthesized region compared with the orig-
inal. We evaluated the variation of T2w by T2w SSIM, s.t.,
dist
(
Iori, Isyn
)
= 1 − SSIM(IoriT2w, IsynT2w), since T2w
typically contains structural information. We measured
the ADC intensity increment of the synthesized region
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Figure 3. The inference of the PCa suspiciousness map using the trained baseline MRI model given an input testing image. The baseline
MRI model synthesizes regions specified from the collection of ROI candidates. dist is the distance function for the original image region
and the synthesized image region.
compared with the original region by dist
(
Iori, Isyn
)
=
max
(
IsynADC− IoriADC, 0
)
since ADC is quantitative imaging,
and PCa lesion usually has lower ADC intensity than nor-
mal tissues [8]. The suspicion for PCa is high if the ADC
intensity in the original region is lower than in the synthe-
sized negative MRI region.
3. Experiments
3.1. Evaluation dataset
A separate independent dataset was used for testing the
cancer inference, which consisted of 116 positive and 116
negative mp-MRI cases. For positive MRI, we included pre-
operative 3T mp-MRI scans prior to robotic-assisted laparo-
scopic prostatectomy from 2013 to 2015. Patients with prior
radiotherapy or hormonal therapy were not included. The
grountruth annotations for positive MRI cases were done
by GU radiologists who retrospectively reviewed mp-MRI,
referring to whole-gland surgical specimens and pathology
reports. Each MRI visible lesion was matched to the cor-
responding location on the prostate specimen through vi-
sual co-registration. Later, clinical research fellows, super-
vised by GU radiologists, annotated all MRI-visible PCa
lesions (Gleason Score≥3+4). We also included prospec-
tively missed PCa lesions (false positives) that are visible
in mp-MRI in a retrospective review, but MRI non-visible
missed PCa lesions were not included in the study. The
negative MRI cases (116 out of 1,261) were from the same
negative prostate MRI dataset pool, described in 2.1. The
ground truth ROIs were annotated on T2w, and the FOV and
slice were determined in the same way.
3.2. Evaluation metrics
The suspiciousness map by the baseline MRI model pre-
dicts pixel-wise levels of overall suspiciousness of prostate
cancer and was used to distinguish between PCa and non-
PCa regions [12, 15]. The PCa lesions were given by the
ground truth ROIs, and non-PCa regions were defined as the
same ground truth ROIs in the negative MRI testing cases.
The average value over the region on the suspiciousness
map is calculated as the predictive value for each ROI. The
performance is evaluated by the receiver operating charac-
teristic (ROC) analysis.
We also evaluated the lesion localization performance
using the free-response receiver operating characteristic
(FROC) analysis [6, 15]. The PCa localization points were
determined by the local maximums of the suspiciousness
map [15]. A localization point was considered as a true
positive if it is within 5mm of a ground truth lesion ROI, or
it is otherwise a false negative [9]. FROC measures the le-
sion detection sensitivity versus the average number of false
positives for each patient.
3.3. Results
Figure 4 shows representative examples of the proposed
cancer inference, evaluated by an independent testing set.
The red contours on both T2w and ADC are the ground
truth annotations, indicating MRI-visible clinically signifi-
cant PCa with histological confirmation. The overall pixel-
wise suspiciousness with two distance functions, T2w SSIM
and ADC Increment, are shown, and the ADC Increment
shows excellent visual predictability of PCa in both cases.
T2W ADC Susp - ADC Incre.Susp - T2W SSIM
1)
2)
Figure 4. The PCa suspiciousness maps with different distance functions for testing images. The red contours on T2w and ADC are the
ground truth ROIs.
(a) (b)
Figure 5. (a) ROC analysis for the classification between PCa lesions and non-PCa regions. (b) FROC analysis for lesion localization
performance.
The ROC analysis for the classification between PCa le-
sions and non-PCa regions is shown in Figure 5. ADC In-
crement (ADC Incre.) achieved the area under the curve
(AUC) of 0.84, while the suspiciousness map using T2w
SSIM exhibited limited predictability for PCa. Compared
with ADC, T2w has a more diverse appearance for the nor-
mal tissues, potentially causing the suboptimal performance
of the cancer inference.
The FROC analysis for lesion localization is shown in
Figure 5. ADC Increment and T2w SSIM had 77.0% and
33.8% detection sensitivity for PCa lesions with 1 false pos-
itive per patient, respectively, and 89.5% and 48.8% detec-
tion sensitivity at 2 false positives per patient. ADC In-
crement received 95% sensitivity at 2.44 false positives per
patient, and T2w SSIM reached its maximum sensitivity of
66.0% at 3.54 false positives per patient.
4. Discussion
We proposed the novel cancer inference that can dis-
tinguish patients with and without PCa using weakly-
supervised learning. We first identified 1,261 radiology-
confirmed negative MRI cases out of all 3,127 in-house
prostate MRI cases from 2016 to 2018. The baseline MRI
model was built to synthesize a partially obstructed MRI
based on the understanding of the negative MRI appear-
ance, and the cancer inference that predicts pixel-wise lev-
els of overall suspiciousness was tested using a combina-
tion of negative and and highly curated positive MRI cases
(n=232). This weakly-supervised learning approach would
be robust to any potential data bias due to the nature of the
very-weak supervision and provides a scalable solution for
training deep learning models.
The PCa detection sensitivity from previous studies
ranged from 38.8% to 89.8% at 1 false positive per pa-
tient in the FROC analysis [6, 13, 15]. Despite the dif-
ferences in dataset and inconsistencies of the lesion defi-
nition, our cancer inference via weakly supervised learning
showed similar performance to the previously demonstrated
models under strong supervision. Compared with the fully-
supervised methods trained with lesion annotations, the pro-
posed method requires only negative MRI scans in training,
which is a more practical and scalable approach to medical
imaging since the method does not require a collection of
large annotated prostate MRI data and is more suitable for
multi-site, multi-vendor collaborations.
The regions are considered to be highly suspicious when
the difference between the original and synthesized regions
is large. We obtained the pixel-wise levels of overall sus-
piciousness by two distance functions, T2w SSIM and ADC
Increment. The primary reason to use these distance func-
tions is that T2w and ADC are typically used for anatomical
and function imaging. Future study could include the inves-
tigation of different distance functions, such as L2 norm and
mutual information.
5. Conclusion
We proposed the baseline MRI model via weakly su-
pervised learning using a large collection of negative mp-
MRI cases. The baseline MRI model was utilized to infer
pixel-wise levels of overall suspiciousness of prostate can-
cer, without the need for using ground truth annotations.
The baseline MRI model was trained and validated using
1145 radiology-confirmed negative mp-MRI scans, and the
cancer inference using the baseline MRI model was tested
by a total of 232 independent mp-MRI scans. The proposed
cancer inference via weakly supervised learning achieved
an AUC of 0.84 in the ROC analysis and 77.0% detection
sensitivity at 1 false positive per patient in the FROC anal-
ysis using a separate dataset with histologically confirmed
lesion annotations.
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